Exogenic Human Heart In Gene Edited Animals

Abstract

Congenital Heart Disease and heart failure are deadly. Cardiac transplantation is the only cure for heart failure and demand for hearts is significantly greater than the supply of donor hearts. The long range goal of this proposal is the production of a humanized heart using NKX2-5/HANDII/TBX5 knockout pigs as hosts for production. These animals may ultimately serve as an organ source for heart transplantation into humans. In addition to serving as a novel source of human hearts for the treatment of heart disease, the humanized pigs will also serve as a large animal model to study the regeneration of the human heart or response(s) to pharmacological agents or novel devices. During the second year of DOD funding we have established a productive cloning laboratory. We have examined multiple hiPSC lines regarding their ability to survive, proliferate and differentiate following delivery to the porcine parthenote blastocysts. Finally, we have initially examined the hiPSC-porcine parthenote chimeras following delivery to pseudopregnant gilts. This strategy has the capacity to have a profound impact on the development of emerging therapies for chronic cardiovascular diseases and transplantation that will benefit our military personnel, veterans and their families.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2017
Accession Number
AD1056728

Entities

People

  • Daniel J Garry

Organizations

  • Regents of the University of Minnesota

Tags

DTIC Thesaurus Topics

  • Blood
  • Cardiovascular Diseases
  • Cells
  • Diseases And Disorders
  • Embryos
  • Engineering
  • Engineers
  • Heart Diseases
  • Heart Failure
  • Medical Personnel
  • Military Personnel
  • Production
  • Regenerative Medicine
  • Stem Cells
  • Transplantation

Fields of Study

  • Biology
  • Medicine

Readers

  • Molecular Biology and Genetics
  • Molecular and Cellular Biology

Technology Areas

  • Biotechnology